IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q3 2024 Holdings

Filed 2024-11-12 | 2 holdings | $8.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biora Therapeutics Inc.COM NEW74319F305$5.5M10,929,76263.1%
Puma Biotechnology Inc(PBYI)COM74587V107$3.2M1,256,41136.9%